Question 1

Selective estrogen receptor modifiers (SERMs) treat osteoporosis by selectively:

Accepted Answer

A)  Inhibiting magnesium resorption in the kidneys 
B)  Increasing calcium absorption from the GI tract 
C)  Acting on the bone to inhibit osteoblast activity 
D)  Selectively acting on the estrogen receptors in the bone 
A)  Inhibiting magnesium resorption in the kidneys 
B)  Increasing calcium absorption from the GI tract 
C)  Acting on the bone to inhibit osteoblast activity 
D)  Selectively acting on the estrogen receptors in the bone D

Question 2

Dosage changes of conjugated equine estrogen (Premarin) are made at _________ intervals.

Accepted Answer

A)  1 to 2 week 
B)  2 to 4 week 
C)  6 to 8 week 
D)  12 week 
A)  1 to 2 week 
B)  2 to 4 week 
C)  6 to 8 week 
D)  12 week C

Question 3

The ongoing monitoring for patients over age 65 years taking alendronate (Fosamax) or any other bisphosphonate is:

Accepted Answer

A)  Annual dual-energy x-ray absorptiometry (DEX
A)  scans 
B)  Annual vitamin D level 
C)  Annual renal function evaluation 
D)  Electrolytes every 3 months 
A)  Annual dual-energy x-ray absorptiometry (DEX
A)  scans 
B)  Annual vitamin D level 
C)  Annual renal function evaluation 
D)  Electrolytes every 3 months C

Question 4

The drug recommended as primary prevention of osteoporosis in women over age 70 years is:

Accepted Answer

A)  Alendronate (Fosamax) 
B)  Ibandronate (Boniva) 
C)  Calcium carbonate 
D)  Raloxifene (Evista) 
A)  Alendronate (Fosamax) 
B)  Ibandronate (Boniva) 
C)  Calcium carbonate 
D)  Raloxifene (Evista)

Question 5

Bisphosphonate administration education includes:

Accepted Answer

A)  Taking it on a full stomach 
B)  Requiring sitting erect for at least 30 minutes afterward 
C)  Drinking it with orange juice 
D)  Taking it with H2 blockers or proton pump inhibitors (PPI) to protect the stomach 
A)  Taking it on a full stomach 
B)  Requiring sitting erect for at least 30 minutes afterward 
C)  Drinking it with orange juice 
D)  Taking it with H2 blockers or proton pump inhibitors (PPI) to protect the stomach

Question 6

Women with an intact uterus should be treated with both estrogen and progestin due to:

Accepted Answer

A)  Increased risk for endometrial cancer if estrogen alone is used 
B)  Combination therapy provides the best relief of menopausal vasomotor symptoms 
C)  Reduced risk for colon cancer with combined therapy 
D)  Lower risk of developing blood clots with combined therapy 
A)  Increased risk for endometrial cancer if estrogen alone is used 
B)  Combination therapy provides the best relief of menopausal vasomotor symptoms 
C)  Reduced risk for colon cancer with combined therapy 
D)  Lower risk of developing blood clots with combined therapy

Question 7

Drugs that increase the risk of osteoporosis developing include:

Accepted Answer

A)  Oral combined contraceptives 
B)  Carbamazepine 
C)  Calcium channel blockers 
D)  High doses of vitamin D 
A)  Oral combined contraceptives 
B)  Carbamazepine 
C)  Calcium channel blockers 
D)  High doses of vitamin D

Question 8

What is the established frequency of repeating DEXA imaging after stating bisphosphonates?

Accepted Answer

A)  Every 2 years 
B)  Every 5 years 
C)  There is no evidence-based time line for monitoring after the first 2 years 
D)  There need to be annual exams 
A)  Every 2 years 
B)  Every 5 years 
C)  There is no evidence-based time line for monitoring after the first 2 years 
D)  There need to be annual exams

Question 9

The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing:

Accepted Answer

A)  Cardiovascular risk 
B)  Risk of stroke or other thromboembolic event 
C)  Breast cancer 
D)  Vasomotor symptoms 
A)  Cardiovascular risk 
B)  Risk of stroke or other thromboembolic event 
C)  Breast cancer 
D)  Vasomotor symptoms

Question 10

Ongoing monitoring for women on ERT includes:

Accepted Answer

A)  Lipid levels, repeated annually if abnormal 
B)  Annual health history and review of risk profile 
C)  Annual mammogram 
D)  All of the above 
A)  Lipid levels, repeated annually if abnormal 
B)  Annual health history and review of risk profile 
C)  Annual mammogram 
D)  All of the above

Question 11

Why are SERMS generally not ordered for women early into menopause?

Accepted Answer

A)  The rapid onset of severe hot flashes can be unbearable. 
B)  The bone remodeling effect results in osteoporosis. 
C)  They tend to induce intermittent spotting. 
D)  They create more risk with breast cancer than they are worth. 
A)  The rapid onset of severe hot flashes can be unbearable. 
B)  The bone remodeling effect results in osteoporosis. 
C)  They tend to induce intermittent spotting. 
D)  They create more risk with breast cancer than they are worth.

Question 12

What is the duration of SERM use for menopausal issues?

Accepted Answer

A)  It matches the 5 years for estrogen products 
B)  The bone health impact allows long-term use 
C)  The increased risk of breast cancer encourages tapering as soon as possible 
D)  The abnormal lipid profile contributes to an early termination as soon as hot flashes no longer occur 
A)  It matches the 5 years for estrogen products 
B)  The bone health impact allows long-term use 
C)  The increased risk of breast cancer encourages tapering as soon as possible 
D)  The abnormal lipid profile contributes to an early termination as soon as hot flashes no longer occur

Question 13

IV forms of bisphosphonates are used for all the following except:

Accepted Answer

A)  Severe gastric irritation with oral forms 
B)  Known cancer mets into the bone 
C)  Persons with advancing renal dysfunction 
D)  Progression of bone loss on oral formulations 
A)  Severe gastric irritation with oral forms 
B)  Known cancer mets into the bone 
C)  Persons with advancing renal dysfunction 
D)  Progression of bone loss on oral formulations

Question 14

The drug recommended as primary prevention of osteoporosis in men over age 70 years is:

Accepted Answer

A)  Alendronate (Fosamax) 
B)  Ibandronate (Boniva) 
C)  Calcium carbonate 
D)  Raloxifene (Evista) 
A)  Alendronate (Fosamax) 
B)  Ibandronate (Boniva) 
C)  Calcium carbonate 
D)  Raloxifene (Evista)

Question 15

Inadequate vitamin D intake can contribute to the development of osteoporosis by:

Accepted Answer

A)  Increasing calcitonin production 
B)  Increasing calcium absorption from the intestine 
C)  Altering calcium metabolism 
D)  Stimulating bone formation 
A)  Increasing calcitonin production 
B)  Increasing calcium absorption from the intestine 
C)  Altering calcium metabolism 
D)  Stimulating bone formation

Question 16

The optimal maximum time frame for HRT or estrogen replacement therapy (ERT) is:

Accepted Answer

A)  2 years 
B)  5 years 
C)  10 years 
D)  15 years 
A)  2 years 
B)  5 years 
C)  10 years 
D)  15 years

Question 17

Sallie has been diagnosed with osteoporosis and is asking about the "once a month" pill to treat her condition. How do bisphosphonates treat osteoporosis?

Accepted Answer

A)  By selectively activating estrogen pathways in the bone 
B)  By reducing bone resorption by inhibiting parathyroid hormone (PTH) 
C)  By reducing bone resorption and inhibiting osteoclastic activity 
D)  By increasing PTH production 
A)  By selectively activating estrogen pathways in the bone 
B)  By reducing bone resorption by inhibiting parathyroid hormone (PTH) 
C)  By reducing bone resorption and inhibiting osteoclastic activity 
D)  By increasing PTH production

Question 18

Angela is a black woman who has heard that women of African descent do not need to worry about osteoporosis. What education would you provide Angela about her risk?

Accepted Answer

A)  She is correct, black women do not have much risk of developing osteoporosis due to their dark skin. 
B)  Black women are at risk of developing osteoporosis due to their lower calcium intake as a group. 
C)  If she doesn't drink alcohol, her risk of developing osteoporosis is low. 
D)  If she has not lost more than 10% of her weight lately, her risk is low. 
A)  She is correct, black women do not have much risk of developing osteoporosis due to their dark skin. 
B)  Black women are at risk of developing osteoporosis due to their lower calcium intake as a group. 
C)  If she doesn't drink alcohol, her risk of developing osteoporosis is low. 
D)  If she has not lost more than 10% of her weight lately, her risk is low.

Question 19

Kristine would like to start HRT to treat the significant vasomotor symptoms she is experiencing during menopause. Education for a woman considering hormone replacement would include:

Accepted Answer

A)  Explaining that HRT is totally safe if used short term 
B)  Telling her to ignore media hype regarding HRT 
C)  Discussing the advantages and risks of HRT 
D)  Encouraging the patient to use phytoestrogens with the HRT 
A)  Explaining that HRT is totally safe if used short term 
B)  Telling her to ignore media hype regarding HRT 
C)  Discussing the advantages and risks of HRT 
D)  Encouraging the patient to use phytoestrogens with the HRT

Question 20

The advantage of vaginal estrogen preparations in the treatment of vulvovaginal atrophy and dryness is:

Accepted Answer

A)  Ability to deliver higher doses of estrogen in a non-oral form 
B)  The vaginal cream formula provides moisture to the vaginal area 
C)  Relief of symptoms without increasing cardiovascular risk 
D)  All of the above 
A)  Ability to deliver higher doses of estrogen in a non-oral form 
B)  The vaginal cream formula provides moisture to the vaginal area 
C)  Relief of symptoms without increasing cardiovascular risk 
D)  All of the above

Exam 38: Hormone Replacement Therapy and Osteoporosis

Selective estrogen receptor modifiers (SERMs) treat osteoporosis by selectively:

Dosage changes of conjugated equine estrogen (Premarin) are made at _________ intervals.

The ongoing monitoring for patients over age 65 years taking alendronate (Fosamax) or any other bisphosphonate is:

The drug recommended as primary prevention of osteoporosis in women over age 70 years is:

Bisphosphonate administration education includes:

Women with an intact uterus should be treated with both estrogen and progestin due to:

Drugs that increase the risk of osteoporosis developing include:

What is the established frequency of repeating DEXA imaging after stating bisphosphonates?

The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing:

Ongoing monitoring for women on ERT includes:

Why are SERMS generally not ordered for women early into menopause?

What is the duration of SERM use for menopausal issues?

IV forms of bisphosphonates are used for all the following except:

The drug recommended as primary prevention of osteoporosis in men over age 70 years is:

Inadequate vitamin D intake can contribute to the development of osteoporosis by:

The optimal maximum time frame for HRT or estrogen replacement therapy (ERT) is:

Sallie has been diagnosed with osteoporosis and is asking about the "once a month" pill to treat her condition. How do bisphosphonates treat osteoporosis?

Angela is a black woman who has heard that women of African descent do not need to worry about osteoporosis. What education would you provide Angela about her risk?

Kristine would like to start HRT to treat the significant vasomotor symptoms she is experiencing during menopause. Education for a woman considering hormone replacement would include:

The advantage of vaginal estrogen preparations in the treatment of vulvovaginal atrophy and dryness is:

The Role of the Nurse Practitioner

Review of Basic Principles of Pharmacology

Rational Drug Selection

Legal and Professional Issues in Prescribing

Adverse Drug Reactions

Factors That Foster Positive Outcomes

Cultural and Ethnic Influences in Pharmacotherapeutics

An Introduction to Pharmacogenomics

Nutrition and Nutraceuticals

Herbal Therapy and Nutritional Supplements

Information Technology and Pharmacotherapeutics

Pharmacoeconomics

Over-The-Counter Medications

Drugs Affecting the Autonomic Nervous System

Drugs Affecting the Central Nervous System

Drugs Affecting the Cardiovascular and Renal Systems

Drugs Affecting the Respiratory System

Drugs Affecting the Hematopoietic System

Drugs Affecting the Immune System

Drugs Affecting the Gastrointestinal System

Drugs Affecting the Endocrine System

Drugs Affecting the Reproductive System

Drugs Affecting the Integumentary System

Drugs Used in Treating Infectious Diseases

Drugs Used in Treating Inflammatory Processes

Drugs Used in Treating Eye and Ear Disorders

Anemia

Chronic Stable Angina and Low-Risk Unstable Angina

Anxiety and Depression

Asthma and Chronic Obstructive Pulmonary Disease

Contraception

Dermatologic Conditions

Diabetes Mellitus

Gastroesophageal Reflux and Peptic Ulcer Disease

Headaches

Heart Failure

Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome

Hyperlipidemia

Hypertension

Hyperthyroidism and Hypothyroidism

Pneumonia

Smoking Cessation

Sexually Transmitted Infections and Vaginitis

Tuberculosis

Upper Respiratory Infections, Otitis Media, and Otitis Externa

Urinary Tract Infections

Women As Patients

Men As Patients

Children As Patients

Geriatric Patients

Pain Management: Acute and Chronic Pain

Filters